Beyond "lower is better" in antithrombotic strategy for coronary artery disease and atrial fibrillation [0.03%]
冠心病和房颤抗栓策略的研究新视角——兼论“越低越好”的局限性
Masanobu Ishii,Taishi Nakamura,Kenichi Tsujita
Masanobu Ishii
Correction: Current updates on latest basic research of scientific relevance in hypertensive dementia [0.03%]
关于高血压痴呆最新基础研究的当前更新（改正）
Masaki Mogi,Yoichi Takami,Masafumi Ihara et al.
Masaki Mogi et al.
Supine hypertension: hemodynamic and neurohumoral mechanisms-reflections on the hypertension research update and perspectives 2025 [0.03%]
仰卧位高血压的血流动力学和神经激素机制：对2025年高血压研究进展和前景的思考
Takeshi Fujiwara,Takahiro Komori,Masato Furuhashi
Takeshi Fujiwara
Enhancing interpretability and clinical integration of machine learning models for home blood pressure monitoring adherence [0.03%]
提高家用血压监测依从性机器学习模型的可解释性和临床适用性的研究
Zekai Yu,Weihao Cheng
Zekai Yu
Evaluation of brain conductivity changes after three-month antihypertensive medication in patients with essential hypertension [0.03%]
原发性高血压患者降压治疗3个月后脑组织电导率变化的评估
Il Suk Sohn,Minseo Kim,Mun Bae Lee et al.
Il Suk Sohn et al.
The study investigates brain conductivity changes following a three-month antihypertensive treatment in 22 patients with essential hypertension. Utilizing a prospective, cross-sectional design, the research employed MREPT for brain conducti...
Early drop in blood pressure following angiotensin receptor-neprilysin inhibitor initiation in decompensated heart failure [0.03%]
心力衰竭失代偿期使用血管紧张素受体脑啡肽酶抑制剂治疗后早期血压下降现象
Takanori Nagahiro,Masaaki Konishi,Eri Kikkoji et al.
Takanori Nagahiro et al.
In a large-scale randomized controlled study of heart failure (HF), angiotensin receptor-neprilysin inhibitors (ARNI) reduced cardiovascular events compared to enalapril, but resulted in more symptomatic hypotension. However, changes in blo...
Feasibility study protocol for the evaluation of home blood pressure in patients receiving angiogenesis inhibitor therapy: a multicenter observational study [0.03%]
家庭血压评估在接受抗血管生成药物治疗的患者中的可行性研究方案——一项多中心观察性研究
Kaori Kitaoka,Satoshi Morimoto,Shintaro Minegishi et al.
Kaori Kitaoka et al.
Elevated blood pressure is frequently observed during cancer treatment with vascular endothelial growth factor inhibitors, reflecting either a treatment-emergent adverse event or pharmacological effect. Appropriate blood pressure management...
A multi-layer retrieval-augmented large language model framework for enhancing hypertension education [0.03%]
一种用于增强高血压教育的多层检索增强大型语言模型框架
Yijun Wang,Yujie Luan,Siyi Cheng et al.
Yijun Wang et al.
Large Language Models (LLMs) demonstrate considerable potential in enhancing the retrieval of health information. However, the hallucinatory they produce poses a security challenge. This study aimed to improve the accuracy and reliability o...
Impact of vascular endothelial growth factor inhibitor-induced hypertension on continued cancer treatment: a systematic review and meta-analysis [0.03%]
血管内皮生长因子抑制剂所致高血压对继续进行癌症治疗的影响：系统评价和meta分析
Maki Nishizaki,Yuma Shibutani
Maki Nishizaki
The administration of bevacizumab, ramucirumab, and aflibercept increases the incidence of hypertension; however, the risk of discontinuation of cancer therapy due to hypertension from these medications remains unclear. A systematic review ...
Why are SGLT2 inhibitors effective in HFpEF? Implications for interstitial fluid retention and cardio-renal interaction [0.03%]
SGLT2抑制剂为何能治疗HFpEF？对间质液潴留和心肾交互作用的启示
Takahiro Masuda,Kazuomi Kariro,Yoshiyuki Morishita
Takahiro Masuda
Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all cases of heart failure and is associated with poor outcomes. Large clinical trials have demonstrated that sodium-glucose cotransporter 2 (SGLT2) inhibito...